Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 27.68% | 25.99% | -0.86% | 1.62% | 17.08% |
| Total Depreciation and Amortization | -5.37% | -3.29% | -29.31% | -31.09% | -29.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.19% | -25.05% | -10.50% | -12.71% | -169.56% |
| Change in Net Operating Assets | -169.79% | -176.12% | -- | -- | -244.60% |
| Cash from Operations | -20.17% | -22.96% | -54.82% | -51.02% | -70.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.89% | -8.89% | -8.00% | -8.00% | 10.89% |
| Issuance of Common Stock | -- | -- | -- | -- | 302,790.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -83.53% | -83.14% | -102.06% | -102.02% | 14,105.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -193.46% | -195.64% | -146.92% | -145.77% | 257.27% |